WHO preferred product characteristics for respiratory syncytial virus (RSV) vaccines

View/ Open
Citation
World Health Organization. (2017). WHO preferred product characteristics for respiratory syncytial virus (RSV) vaccines. World Health Organization. http://www.who.int/iris/handle/10665/258705. License: CC BY-NC-SA 3.0 IGO
Description
15 p.Gov't Doc #
WHO/IVB/17.11Collections
Language
EnglishMetadata
Show full item recordRelated items
Showing items related by title and MeSH subject.
-
Circulation of Respiratory Syncytial Virus in Morocco during 2014-2016: Findings from a sentinel-based virological surveillance system for influenza
Bimouhen, A.; El Falaki, F.; Ihazmad, H.; Regragui, Z.; Benkerroum, S.; Barakat, A. (2016-07)Respiratory syncytial virus [RSV] is a leading cause of mortality and morbidity in young infants, little was known on its circulation types and patterns in Morocco. We conducted a prospective study using sentinel-based influenza surveillance to detect RSV by real time PCR in patients with acute respiratory infections, enrolled during two seasons [2014/15, 2015/16]. During September 2014-April 2016, we obtained 1450 specimens, of which 267 [18.4%] tested positive for RSV. The proportion of positive RSV infection was higher in patients hospitalized ... -
WHO informal consultation on surveillance of respiratory syncytial virus on the WHO Global Influenza Surveillance and Response System (GISRS) platform, 25–27 March 2015, Geneva, Switzerland = Surveillance du virus respiratoire syncytial par le biais du système mondial OMS de surveillance de la grippe et de riposte: consultation informelle convoquée par l’OMS du 25 au 27 mars 2015 à Genève, Suisse
World Health Organization = Organisation mondiale de la Santé (2016-01-08)